GoodRx & Novo Nordisk Unlock GLP-1 Access
GoodRx partnered with Novo Nordisk to offer Ozempic and Wegovy pens for $499/month to self-paying patients, expanding access for those without adequate insurance. This makes them available at over 70,000 U.S. pharmacies. Hims & Hers down.
This post is for paying subscribers only
Already have an account? Sign in.